Circle Pharma

3 articles about Circle Pharma

• Circle Pharma Appoints Stephen Kelsey, MB ChB, MD, to its Board of Directors

  12/15/2022

  Circle Pharma, a company focused on developing macrocycle therapeutics against targets previously considered to be undruggable, has appointed Stephen Kelsey as an independent member of its Board of Directors.

• Circle Pharma Appoints Evelyn Wang, PhD as its Vice President, Translational Medicine

  7/12/2021

  Evelyn Wang, PhD has joined Circle Pharma as its Vice President of Translational Medicine and will lead Circle’s translational team in its development of macrocycle therapeutics against intractable cancer targets.

• Circle Pharma Raises $66 Million in Series C Financing

  6/16/2021

  Circle Pharma, Inc.today announced that it has raised $66 million in an oversubscribed Series C financing.